Big pharma reaps big profits from single drugs

08/21/2013 | Quartz

Of the world's 11 largest pharmaceutical companies, six market a single drug that represented more than 10% of their total sales last year, according to journalist David Yanofsky. The company with the biggest portion of net sales in one drug was Abbott Laboratories with its rheumatoid arthritis treatment Humira, which accounted for more than 23% of the firm's sales, followed by Eli Lilly & Co., whose antidepressant Cymbalta made up more than 22% of net sales. The big exception: highly diversified Bayer, with no single product taking more than 5% of sales.

View Full Article in:

Quartz

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ